Since 2020, variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) have become a global threat. The first subspecies (alpha subspecies) was discovered in the United...
Recent preprints available at bioRxiv* Preprint server describes antibody response to Nucleic acid A vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when administered to...
.jpg)
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 results in a B-cell response that lasts for at least...
.jpg)
The deployment of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is expanding worldwide. However, little is known about the duration of protection provided by...
As of October 7, 2021, Coronavirus Disease 2019 (COVID-19) has killed more than 4.82 million people worldwide. Much research is being encouraged by the need to...
Your saliva may tell you if you have developed the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody, suggesting something new medRxiv* Preprint survey. In the...
Recent Comments